摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(二乙基氨基)辛基3,4,5-三甲氧基苯甲酸酯 | 57818-92-5

中文名称
8-(二乙基氨基)辛基3,4,5-三甲氧基苯甲酸酯
中文别名
——
英文名称
8-(Diethylamino)octyl 3,4,5-trimethoxybenzoate
英文别名
——
8-(二乙基氨基)辛基3,4,5-三甲氧基苯甲酸酯化学式
CAS
57818-92-5
化学式
C22H37NO5
mdl
——
分子量
395.5
InChiKey
IBQMHBGFMLHHLE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    28
  • 可旋转键数:
    16
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    57.2
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • [EN] ALKAMIDE COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS ALKAMIDE ET UTILISATIONS ASSOCIÉES
    申请人:UNIV NORTH CAROLINA STATE
    公开号:WO2019071093A1
    公开(公告)日:2019-04-11
    The present disclosure relates to alkamide compounds and compositions for treating allergic diseases, pain, or itch.
    本公开涉及酰胺化合物和用于治疗过敏性疾病、疼痛或瘙痒的组合物。
  • Preparation of prodrugs for selective drug delivery
    申请人:Mills L. Randell
    公开号:US20050080260A1
    公开(公告)日:2005-04-14
    Synthesis of a chemical compound having the formula A-B-C that may serve for applications such as drug delivery where A is a chemiluminescent, moiety, B is a photochromic moiety, and C is a biologically active moiety where A-B-C may serve as a prodrug. Novel synthetic methods of the present invention to form the prodrug comprised the steps of (1) forming a benzophenone, (2) forming a diaryl ethylene, (3) attaching a phthalimide moiety to at least one of the aryl groups of the ethylene to form a phthalimide-ethylene conjugate, (4) condensing two ethylene-phthalimide conjugates to form a phthalimide-pentadiene conjugate, (5) converting the phthalimide to the phthalhydrazide by reaction with hydrazine to form a carrier compound according to the present invention, and (6) reacting the carrier compound with an nucleophilic moiety of the drug to form the corresponding prodrug. Alternatively the carrier can be prepared by using the halo-substituted diaryl ethylene to make the corresponding cationic leuco dye-like compound with known methods. The cationic compound then is protected by reacting with a nucleophile and coupled with the aminophathalimide by palladium-catalyzed amination to form the protected phthalimide-pentadiene conjugate. The latter is refluxed with hydrazine to convert its phthalimide to the phthalhydrazide and acidified to give the carrier. An additional aspect of the present invention relates to the use of these compounds as antiviral agents for the treatment of viral infections such as HIV and as anticancer agents for the treatment of cancers such as bowel, lung, and breast cancer.
    合成具有A-B-C化学式的化合物,可用于药物传递等应用,其中A是化学发光基团,B是光致变色基团,C是生物活性基团,其中A-B-C可作为前药。本发明的新型合成方法用于形成前药,包括以下步骤:(1)形成,(2)形成二芳基乙烯,(3)将邻二甲酰亚胺基团连接到乙烯的至少一个芳基上,形成邻二甲酰亚胺-乙烯共轭物,(4)缩合两个乙烯-邻二甲酰亚胺共轭物,形成邻二甲酰亚胺-戊二烯共轭物,(5)通过与反应将邻二甲酰亚胺转化为邻二酰,形成本发明的载体化合物,(6)将载体化合物与药物的亲核基团反应,形成相应的前药。另外,可以通过使用卤代二芳基乙烯制备相应的阳离子类似的类似类似染料化合物。然后,通过与亲核试剂反应保护阳离子类似化合物,并通过催化的胺化与基邻二甲酰亚胺偶联,形成保护的邻二甲酰亚胺-戊二烯共轭物。后者与回流,将其邻二甲酰亚胺转化为邻二酰,并酸化以得到载体。本发明的另一个方面涉及将这些化合物用作抗病毒剂,用于治疗病毒感染,如HIV,以及用作抗癌剂,用于治疗结肠癌、肺癌和乳腺癌等癌症。
  • HAIR GROWTH STIMULANT
    申请人:SHISEIDO COMPANY LIMITED
    公开号:EP0428754A1
    公开(公告)日:1991-05-29
    A hair growth stimulant comprising an amine oxide and a calmodulin inhibitor and/or a calcium antagonist.
    化胺和调蛋白抑制剂和/或拮抗剂组成的生发刺激剂。
  • Reduction of hair growth
    申请人:——
    公开号:US20030153619A1
    公开(公告)日:2003-08-14
    Mammalian hair growth can be reduced by topical application of an inhibitor of fatty acid metabolism.
    局部使用脂肪酸代谢抑制剂可减少哺乳动物毛发的生长。
  • Small molecules that reduce fungal growth
    申请人:Johnson I. Douglas
    公开号:US20060194769A1
    公开(公告)日:2006-08-31
    The present invention relates to methods for reducing the growth of a fungus with an anti-fungal small molecule. Methods for reducing fungal cell growth in a subject with an anti-fungal small molecule and related compositions are provided. Topical lotion formulations of an anti-fungal small molecule and a topical carrier are also provided.
    本发明涉及用抗真菌小分子减少真菌生长的方法。本发明提供了用抗真菌小分子和相关组合物减少受试者体内真菌细胞生长的方法。还提供了抗真菌小分子和局部载体的局部洗剂配方。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫